130 related articles for article (PubMed ID: 9933479)
1. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts.
Sasaki-Iwaoka H; Maruyama K; Endoh H; Komori T; Kato S; Kawashima H
J Bone Miner Res; 1999 Feb; 14(2):248-55. PubMed ID: 9933479
[TBL] [Abstract][Full Text] [Related]
2. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
Xiao ZS; Hinson TK; Quarles LD
J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
[TBL] [Abstract][Full Text] [Related]
3. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
Ishibashi O; Yamagishi T; Hanada K; Kawashima H
Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
[TBL] [Abstract][Full Text] [Related]
5. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
6. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
Shui C; Spelsberg TC; Riggs BL; Khosla S
J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
[TBL] [Abstract][Full Text] [Related]
7. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
9. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
Hyder SM; Nawaz Z; Chiappetta C; Stancel GM
Cancer Res; 2000 Jun; 60(12):3183-90. PubMed ID: 10866309
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
Tou L; Quibria N; Alexander JM
Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites.
Petz LN; Ziegler YS; Schultz JR; Kim H; Kemper JK; Nardulli AM
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):113-22. PubMed ID: 15084343
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
15. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes.
Kern B; Shen J; Starbuck M; Karsenty G
J Biol Chem; 2001 Mar; 276(10):7101-7. PubMed ID: 11106645
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs).
Tou L; Quibria N; Alexander JM
Mol Cell Endocrinol; 2001 Oct; 183(1-2):71-9. PubMed ID: 11604227
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
18. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
19. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function.
Thirunavukkarasu K; Halladay DL; Miles RR; Yang X; Galvin RJ; Chandrasekhar S; Martin TJ; Onyia JE
J Biol Chem; 2000 Aug; 275(33):25163-72. PubMed ID: 10833509
[TBL] [Abstract][Full Text] [Related]
20. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.
Fan JD; Wagner BL; McDonnell DP
Mol Endocrinol; 1996 Dec; 10(12):1605-16. PubMed ID: 8961270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
